Ravoxertinib

**Semantic type:** Pharmacologic Substance

**Definition:** An orally available inhibitor of extracellular signal-regulated kinase (ERK), with potential antineoplastic activity. Upon oral administration, ravoxertinib inhibits both ERK phosphorylation and activation of ERK-mediated signal transduction pathways. This prevents ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival.

**Synonyms:** - ERK Inhibitor GDC-0994 - GDC-0994 - RAVOXERTINIB